We are live on
!
Find out more
FCM
Frontier Capital Management Portfolio holdings
AUM
$9.73B
1-Year Est. Return
55.65%
This Fund
S&P 500
This Quarter
Est. Return
+11.26%
1 Year Est. Return
+55.65%
3 Year Est. Return
+154.46%
5 Year Est. Return
+213.15%
10 Year Est. Return
+1,202.39%
AUM
$13.5B
AUM Growth
+$766M
(+6%)
Cap. Flow
-$317M
Cap. Flow
% of AUM
-2.34%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
307
New
18
Increased
98
Reduced
164
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Quanta Services
PWR
|
+$87.3M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
+$74.4M |
| 3 |
XYZ
Block Inc
XYZ
|
+$74.1M |
| 4 |
Webster Financial
WBS
|
+$62.3M |
| 5 |
MDLA
Medallia, Inc.
MDLA
|
+$49.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$89.8M |
| 2 |
WEX
WEX
|
+$87.9M |
| 3 |
INXN
Interxion Holding N.V.
INXN
|
+$64.8M |
| 4 |
Exelixis
EXEL
|
+$63.5M |
| 5 |
Dollar General
DG
|
+$50.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.5% |
| 2 | Technology | 18.21% |
| 3 | Consumer Discretionary | 13.66% |
| 4 | Healthcare | 13.01% |
| 5 | Financials | 12.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Nektar Therapeutics
NKTR
$2.39B
| $14.4M | 0.11% |
44,427
-8,500
| -16% | -$2.46M |
|
|
BCOV
202
DELISTED
Brightcove, Inc.
BCOV
| $14.3M | 0.11% |
1,647,024
-167,321
| -9% | -$1.57M |
|
203
Acadia Healthcare
ACHC
$2.52B
| $14M | 0.1% |
422,653
-44,258
| -9% | -$1.39M |
|
204
Nutanix
NTNX
$16.1B
| $14M | 0.1% |
+446,332
| New | +$13.2M |
|
205
Martin Marietta Materials
MLM
$34.2B
| $13.7M | 0.1% |
48,879
-5,019
| -9% | -$1.34M |
|
|
GLOG
206
DELISTED
GASLOG LTD
GLOG
| $13.6M | 0.1% |
1,393,569
+16,707
| +1% | +$190K |
|
207
Raymond James Financial
RJF
$33.5B
| $13.6M | 0.1% |
227,934
-24,225
| -10% | -$1.4M |
|
208
PJT Partners
PJT
$4.26B
| $13.3M | 0.1% |
+294,790
| New | +$12.4M |
|
|
AERI
209
DELISTED
Aerie Pharmaceuticals
AERI
| $13.2M | 0.1% |
544,215
-2,141
| -0.4% | -$44.3K |
|
210
W.R. Berkley
WRB
$28.1B
| $12.9M | 0.1% |
419,765
-87,360
| -17% | -$2.7M |
|
|
ZUO
211
DELISTED
Zuora, Inc.
ZUO
| $12.8M | 0.09% |
892,686
-487,214
| -35% | -$7.14M |
|
|
BLUE
212
DELISTED
bluebird bio
BLUE
| $12.6M | 0.09% |
11,090
+7,729
| +230% | +$8.4M |
|
|
TWOU
213
DELISTED
2U Inc
TWOU
| $12.5M | 0.09% |
17,376
-1,344
| -7% | -$836K |
|
214
FIVE9
FIVN
$2.08B
| $12.4M | 0.09% |
188,810
-77,519
| -29% | -$4.74M |
|
215
Darling Ingredients
DAR
$9.32B
| $12.3M | 0.09% |
439,126
-42,305
| -9% | -$943K |
|
|
CVA
216
DELISTED
Covanta Holding Corporation
CVA
| $11.8M | 0.09% |
797,328
+68,488
| +9% | +$1.04M |
|
217
PRA Group
PRAA
$672M
| $11M | 0.08% |
303,032
-28,802
| -9% | -$1.02M |
|
|
BHVN
218
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $10.7M | 0.08% |
196,315
+107,033
| +120% | +$5.3M |
|
219
Granite Construction
GVA
$5.16B
| $10.7M | 0.08% |
385,090
+130,173
| +51% | +$3.7M |
|
|
GBT
220
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $10.7M | 0.08% |
134,000
+72,816
| +119% | +$4.32M |
|
221
Tandem Diabetes Care
TNDM
$1.27B
| $10.4M | 0.08% |
174,999
-25,866
| -13% | -$1.6M |
|
222
Artisan Partners
APAM
$2.86B
| $10.1M | 0.07% |
312,655
-30,252
| -9% | -$874K |
|
223
Adaptive Biotechnologies
ADPT
$3.61B
| $9.82M | 0.07% |
+328,357
| New | +$9.43M |
|
224
Jefferies Financial Group
JEF
$12.7B
| $9.7M | 0.07% |
474,926
-45,092
| -9% | -$853K |
|
225
Graphic Packaging
GPK
$3.35B
| $9.51M | 0.07% |
570,898
-182,156
| -24% | -$2.89M |
|
Similar funds
HL
DCP
CCM
URS
CIM
MPI
TIM
DPIM
Frontier Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Frontier Capital Management held 307 positions worth $13.5B, up 6% from $12.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Frontier Capital Management's Q4 2019 filing shows 18 new, 98 increased, 164 reduced and 26 closed positions. Its largest new stake was Block Inc: 1,159,761 shares worth $72.6M. The largest sale was Fidelity National Information Services, an estimated $89.8M.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Frontier Capital Management's largest Q4 2019 buy was Block Inc: 1,159,761 shares worth $72.6M.
- Frontier Capital Management added most to Quanta Services in Q4 2019, an estimated $87.3M increase.
- Frontier Capital Management's biggest Q4 2019 reduction was WEX, cutting an estimated $87.9M.
- Frontier Capital Management fully exited Fidelity National Information Services in Q4 2019, selling an estimated $89.8M.
- Frontier Capital Management's ten largest holdings make up 15% of its $13.5B portfolio in Q4 2019.
- Frontier Capital Management opened 18 new positions and closed 26 in Q4 2019.
- Frontier Capital Management's portfolio value rose 6% quarter-over-quarter to $13.5B.
Based on Frontier Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.